Find Dalcetrapib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 211513-37-0, Jtt-705, Dalcetrapib (jtt-705, ro4607381), Ro4607381, Ro-4607381, Jtt 705
Molecular Formula
C23H35NO2S
Molecular Weight
389.6  g/mol
InChI Key
YZQLWPMZQVHJED-UHFFFAOYSA-N
FDA UNII
3D050LIQ3H

Dalcetrapib
Dalcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrapib, and raises functional HDL by a different mechanism.
1 2D Structure

Dalcetrapib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate
2.1.2 InChI
InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)
2.1.3 InChI Key
YZQLWPMZQVHJED-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C
2.2 Other Identifiers
2.2.1 UNII
3D050LIQ3H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Jtt 705

2. Jtt-705

3. Jtt705

4. Ro-4607381

5. Ro4607381

6. S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate

2.3.2 Depositor-Supplied Synonyms

1. 211513-37-0

2. Jtt-705

3. Dalcetrapib (jtt-705, Ro4607381)

4. Ro4607381

5. Ro-4607381

6. Jtt 705

7. Jtt705

8. S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate

9. 2-methylpropanethioic Acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] Ester

10. 3d050liq3h

11. Chembl313006

12. S-(2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl) 2-methylpropanethioate

13. S-2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl 2-methylpropanethioate

14. S-[2-({[1-(2-ethylbutyl)cyclohexyl]carbonyl}amino)phenyl] 2-methylpropanethioate

15. Thioisobutyric Acid S-(2-{[1-(2-ethyl-butyl)-cyclohexanecarbonyl]-amino}-phenyl) Ester

16. Rg-1658

17. Dalcetrapib [mi]

18. Dalcetrapib [inn]

19. Dalcetrapib (usan/inn)

20. Dalcetrapib [usan:inn]

21. Dalcetrapib [usan]

22. Dalcetrapib (jtt-705)

23. Unii-3d050liq3h

24. Dalcetrapib [who-dd]

25. Schembl528622

26. Chebi:95001

27. Dalcetrapib, >=97% (hplc)

28. Dtxsid70943475

29. Ex-a092

30. Bcpp000268

31. Hms3656f06

32. Amy21305

33. Zinc3976476

34. Bdbm50092197

35. Mfcd06407886

36. S2772

37. Dalcetrapib Pound Jtt-705 Pound(c)

38. Akos015966940

39. Bcp9000580

40. Ccg-264995

41. Cs-0916

42. Db12181

43. Pb12356

44. S-(2-(1-(2-ethylbutyl)cyclohexane-1-carboxamido)phenyl) 2-methylpropanethioate

45. Ncgc00386198-05

46. Ac-27462

47. As-55940

48. Hy-14950

49. Dalcetrapib (jtt-705; Ro-4607381)

50. Ft-0769704

51. Sw219843-1

52. A25148

53. D09708

54. J-510086

55. Q5210285

56. Brd-k18849474-001-01-0

57. Jtt-705;s-2-(2-ethylbutyl)-2-formamidocyclohexyl 2-methyl-2-phenylpropanethioate

58. S-[2-[1-(2-ethylbutyl)cyclohexanecarbonylamino]-phenyl] 2-methylthiopropionate

59. Propanethioic Acid, 2-methyl-, S-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino)phenyl) Ester

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 389.6 g/mol
Molecular Formula C23H35NO2S
XLogP37.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count9
Exact Mass389.23885053 g/mol
Monoisotopic Mass389.23885053 g/mol
Topological Polar Surface Area71.5 Ų
Heavy Atom Count27
Formal Charge0
Complexity481
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Lipoprotein deficiency


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anticholesteremic Agents

Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty